Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA(B) receptor antagonists (Q43719531)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2001

Language	Label	Description	Also known as
English	Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA(B) receptor antagonists	scientific article published in September 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA(B) receptor antagonists (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Pittaluga A

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Feligioni M

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Ghersi C

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Gemignani A

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Raiteri M

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

301-310

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Molecular biology of somatostatin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

A synaptic model of memory: long-term potentiation in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Multiple GABAB receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Selective block of rat and human neocortex GABA(B) receptors regulating somatostatin release by a GABA(B) antagonist endowed with cognition enhancing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Human brain somatostatin release from isolated cortical nerve endings and its modulation through GABAB receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

A presynaptic N-methyl-D-aspartate autoreceptor in rat hippocampus modulating amino acid release from a cytoplasmic pool

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Cysteamine-induced depletion of central somatostatin-like immunoactivity: effects on behavior, learning, memory and brain neurochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Molecular pharmacology of somatostatin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

In vivo release of somatostatin from rat hippocampus and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

FK960, a novel potential anti-dementia drug, augments long-term potentiation in mossy fiber-CA3 pathway of guinea-pig hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

CGP 36742: the first orally active GABAB blocker improves the cognitive performance of mice, rats, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Selective depletion of somatostatin in rat brain by cysteamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Somatostatin potentiates NMDA receptor function via activation of InsP(3) receptors and PKC leading to removal of the Mg(2+) block without depolarization

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Synaptosomes still viable after 25 years of superfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

A simple apparatus for studying the release of neurotransmitters from synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Brain somatostatin: Receptor-coupled transducing mechanisms and role in cognitive functions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPgammaS binding

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Facilitation of glutamate receptors enhances memory

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900066-1

7 January 2021

Identifiers

10.1016/S0028-3908(01)00066-1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43719531&oldid=2102816133"